lot pay top-lin growth
retain forecast organ sale growth margin
increas last year step-up organ sale growth us
group sale impress
gerber relaunch realli gain traction initi
plan frozen food year conceiv could see
acceler contrast growth neglig europ nespresso
drag region sale temporari delist
product remain seen roll-out kick-start
growth em growth benefit greater price rel easi
compar latin america
littl chang estim ex-curr nestl organ
growth margin increas in-lin expect increas
oper profit estim entir reflect slightli weaker sfr
sinc last updat model increas estim
underli ep addit incorpor slightli lower tax charg
roll acceler buy-back
time fy cash flow stronger expect driven
reduct work capit
valuat nestl trade pe think
incorpor defens premium base nestl diversifi portfolio
rel strong balanc sheet swiss domicil see risk
weight downsid particularli given prospect slow start
year rais apv-deriv price target reflect
stronger cash flow roll model
weaker sfr increas market valu nestl sharehold
loral price target impli pe base
apv adjust present valu chang assumpt cost
equiti termin growth rate upsid risk includ better
expect top-lin growth
valuat metric
price month
price rel chart measur perform
swiss market ind close
spot exchang rate
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
nestl sa swiss compani engag nutrit health
well sector hold compani nestl group
compris subsidiari associ compani joint
ventur throughout world
price feb rate under-perform target price analyst alan erskin
profit tax
associ
chang work capit
cash non-cash item
flow oper
free cash-flow firm
flow invest
issuanc retir debt
cash-flow financ
chang net cash/debt
scenario assum nestl deliv organ
sale growth fade margin expand
net debt start
chang net debt
net debt end
total equiti liabil
share wtd average mn
ratio valuat
net debt ebitda
grey scenario assum consum spend slow
put pressur nestl top-lin profit
scenario assum organ sale growth margin
expand per annum
price rel chart measur perform swiss market
ind close
spot exchang rate
compani mention price
